STERIS Future Growth

Future criteria checks 1/6

STERIS is forecast to grow earnings and revenue by 12.2% and 6.1% per annum respectively. EPS is expected to grow by 12.1% per annum. Return on equity is forecast to be 11.9% in 3 years.

Key information

12.2%

Earnings growth rate

12.1%

EPS growth rate

Medical Equipment earnings growth16.6%
Revenue growth rate6.1%
Future return on equity11.9%
Analyst coverage

Good

Last updated07 Jun 2024

Recent future growth updates

Recent updates

Is STERIS (NYSE:STE) Using Too Much Debt?

Jun 13
Is STERIS (NYSE:STE) Using Too Much Debt?

Steris: Moving On, Losing Its Teeth

Apr 14

STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

Mar 29
STERIS plc's (NYSE:STE) Intrinsic Value Is Potentially 31% Above Its Share Price

STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Mar 07
STERIS (NYSE:STE) Has A Pretty Healthy Balance Sheet

Steris: Strong Healthcare Products Growth Coupled With Weak AST Business

Feb 17

STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

Feb 15
STERIS plc's (NYSE:STE) Business Is Trailing The Industry But Its Shares Aren't

An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Dec 17
An Intrinsic Calculation For STERIS plc (NYSE:STE) Suggests It's 23% Undervalued

Should You Investigate STERIS plc (NYSE:STE) At US$203?

Nov 24
Should You Investigate STERIS plc (NYSE:STE) At US$203?

Steris: Comprehensive Sterilization Portfolios Tailored To Procedure Volumes

Nov 08

We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

Nov 06
We Think STERIS (NYSE:STE) Can Stay On Top Of Its Debt

Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Sep 18
Are STERIS plc (NYSE:STE) Investors Paying Above The Intrinsic Value?

Steris: Remains On Track For Strong Fiscal '24, Added Upsides From Operating Leverage

Sep 01

When Should You Buy STERIS plc (NYSE:STE)?

Aug 10
When Should You Buy STERIS plc (NYSE:STE)?

Steris: Continuing To Grow The Product Lineup

Jun 20

Steris falls 10% on Q3 revenue, profit miss, 2023 profit guidance lowered

Feb 09

Steris declares $0.47 dividend

Feb 01

These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

Feb 01
These 4 Measures Indicate That STERIS (NYSE:STE) Is Using Debt Reasonably Well

Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Dec 28
Calculating The Intrinsic Value Of STERIS plc (NYSE:STE)

Steris declares $0.47 dividend

Nov 02

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Nov 01
STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Steris: Non-GAAP Valuations Supportive Of Substantial Upside

Sep 04

STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

Aug 18
STERIS (NYSE:STE) Will Pay A Larger Dividend Than Last Year At $0.47

STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

Aug 04
STERIS' (NYSE:STE) Dividend Will Be Increased To $0.47

Steris Non-GAAP EPS of $1.90 in-line, revenue of $1.2B misses by $20M

Aug 02

Is STERIS (NYSE:STE) A Risky Investment?

Jul 19
Is STERIS (NYSE:STE) A Risky Investment?

Steris: Deleveraging Key Undercurrent, Valuation A Concern

Jun 12

STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Apr 08
STERIS (NYSE:STE) Seems To Use Debt Quite Sensibly

Earnings and Revenue Growth Forecasts

NYSE:STE - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/20276,1568911,2761,6565
3/31/20265,8357581,1011,3538
3/31/20255,5296587971,1159
3/31/20245,139551613973N/A
12/31/20235,407567594934N/A
9/30/20235,228550535849N/A
6/30/20235,086119494806N/A
3/31/20234,536557395757N/A
12/31/20224,784-28349713N/A
9/30/20224,777-8399752N/A
6/30/20224,773377472819N/A
3/31/20224,223285397685N/A
12/31/20214,248279412701N/A
9/30/20213,848250400662N/A
6/30/20213,407286424653N/A
3/31/20213,108397450690N/A
12/31/20203,057433476701N/A
9/30/20203,022424400627N/A
6/30/20203,003413384615N/A
3/31/20203,031408376591N/A
12/31/20192,976393340570N/A
9/30/20192,898336347573N/A
6/30/20192,840319336548N/A
3/31/20192,782304350540N/A
12/31/20182,730269325490N/A
9/30/20182,696316314467N/A
6/30/20182,651303321478N/A
3/31/20182,620291292458N/A
12/31/20172,585243N/A463N/A
9/30/20172,570144N/A453N/A
6/30/20172,582120N/A424N/A
3/31/20172,613110N/A424N/A
12/31/20162,616142N/A439N/A
9/30/20162,588167N/A364N/A
6/30/20162,431135N/A294N/A
3/31/20162,233111N/A255N/A
12/31/20152,04294N/A185N/A
9/30/20151,897113N/A221N/A
6/30/20151,870135N/A241N/A
3/31/20151,842135N/A246N/A
12/31/20141,807133N/A233N/A
9/30/20141,739123N/A234N/A
6/30/20141,660122N/A223N/A
3/31/20141,615129N/A210N/A
12/31/20131,585132N/A189N/A
9/30/20131,560152N/A196N/A
6/30/20131,533162N/A199N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: STE's forecast earnings growth (12.2% per year) is above the savings rate (2.4%).

Earnings vs Market: STE's earnings (12.2% per year) are forecast to grow slower than the US market (14.9% per year).

High Growth Earnings: STE's earnings are forecast to grow, but not significantly.

Revenue vs Market: STE's revenue (6.1% per year) is forecast to grow slower than the US market (8.7% per year).

High Growth Revenue: STE's revenue (6.1% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: STE's Return on Equity is forecast to be low in 3 years time (11.9%).


Discover growth companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.